Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share News

234567891011

Scancell Holdings To Present Phase I/II ImmunoBody Trial Data At ASCO

15th May 2014 12:46

LONDON (Alliance News) - Scancell Holdings PLC said Thursday that it will announce the latest data from its ongoing Phase I/II clinical trial of its SCIB1 ImmunoBody treatment for stage III/IV melanoma will be presented at the American Society of Clinical Oncology meeting in Chicago at the end of Read More

UK MIDDAY BRIEFING: Lloyds Kicks Off Bank Season With Improvement

1st May 2014 13:03

LONDON (Alliance News) - <strong>Lloyds Banking Group</strong> kicked off the first-quarter bank earnings season Thursday, reporting that its pretax profit dropped by a third to GBP1.37 billion after last year was buoyed by gains on the sale of government securities.<br /><br />However, its un Read More

UK WINNERS & LOSERS: Lloyds Atop FTSE 100 Risers; Weir Leads Fallers

1st May 2014 11:27

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Lloyds Banking</strong> Group, up 4.8%. The banking group is the biggest riser in the Read More

Scancell Rises As Long-Time Consultant Joins Its Board

1st May 2014 10:29

LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC saw its shares rise Thursday after it appointed long-time consultant Dr Sally Adams to its board as development director with immediate effect. In a statement, the company, which is developing immunotherapies to treat Read More

Scancell To Announce Phase I/II Of Melanoma Clinical Trial On April 8

4th Apr 2014 09:55

LONDON (Alliance News) - Scancell Holdings PLC Friday said that it will announce the results of phase one and two of its clinical trial in patients with stage three and four melanoma at the American Association for Cancer Research annual meeting in San Diego next Tuesday. Scancell Holdings Read More

Scancell Holdings Completes Phase 1 Of Melanoma Clinical Trial

21st Mar 2014 09:11

LONDON (Alliance News) - Scancell Holdings PLC Friday said it has completed patient dosing with 8mg of SCIB1 ImmunoBody in part one of its on-going phase 1/2 clinical trial in patients with Stage III/IV melanoma. The trial followed a study the firm conducted which showed that a 4mg dose of Read More

Scancell Says Patent Application For Cancer Fighting Platform Published

18th Feb 2014 09:19

LONDON (Alliance News) - Scancell Holdings PLC Tuesday said its patent application for Moditope has been published, with a view to guarding the platform until 2033 once the patent is granted. In a statement, Scancell said the application for the Modicope platform describes how it uses certa Read More

Scancell Gets US Orphan Drug Tag For Metastatic Melanoma Treatment

11th Feb 2014 09:50

LONDON (Alliance News) - Scancell Holdings PLC said Tuesday its SCIB1 ImmunoBody metastatic melanoma treatment had been granted orphan drug designation by the US Food and Drug Administration. This designation means that Scancell can qualify for a 50% tax credit for clinical trials of the tr Read More

CORRECT: UK MORNING BRIEFING: Shares Open Higher But Barclays Down On Results

11th Feb 2014 09:36

<span style="color: #333333; font-family: HelveticaNeue, 'Helvetica Neue', HelveticaNeueRoman, HelveticaNeue-Roman, 'Helvetica Neue Roman', TeXGyreHerosRegular, Helvetica, Tahoma, Geneva, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 300; letter-spa Read More

UK MORNING BRIEFING: Shares Open Higher But Barclays Down On Results

11th Feb 2014 08:32

LONDON (Alliance News) - UK shares have opened higher Tuesday ahead of the testimony later in the day by new US Federal Reserve Chair Janet Yellen. <br /><br /><strong>Barclays</strong> has said it is in a position to increase its leverage ratio target, despite a loss in its final quarter. Bar Read More

Scancell To Boost Moditope Team After Getting Nottingham Grant

6th Jan 2014 08:27

Read More

Scancell Gets Ichor Extension, But Agrees To Waive Options Lock In

18th Nov 2013 10:25

Read More

DIRECTOR DEALINGS: Scancell Directors Sell Shares

22nd Oct 2013 09:48

Read More

Scancell DNA Immunotherapy Technology Granted Patent In Australia

3rd Sep 2013 10:44

Read More

234567891011
FTSE 100 Latest
Value9,897.42
Change59.65